Reduced steady state-based peripheral blood stem cell harvest rate in multiple myeloma treated with bortezomib-based induction regimens

Leukemia. 2012 Dec;26(12):2552-4. doi: 10.1038/leu.2012.138. Epub 2012 May 25.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / administration & dosage
  • Bortezomib
  • Dexamethasone / administration & dosage
  • Doxorubicin / administration & dosage
  • Follow-Up Studies
  • Hematopoietic Stem Cell Mobilization*
  • Humans
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Peripheral Blood Stem Cell Transplantation
  • Prognosis
  • Pyrazines / administration & dosage
  • Remission Induction
  • Retrospective Studies
  • Stem Cells / drug effects*
  • Thalidomide / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Boronic Acids
  • Pyrazines
  • Thalidomide
  • Vincristine
  • Bortezomib
  • Dexamethasone
  • Doxorubicin